scorecardresearch
Add as a preferred source on Google
Sunday, September 20, 2026
Celebrating 9 Years
Support Our Journalism

Support our Journalism

9th Anniversary: Free Tote & Mug

Subscribe
TopicCovid drug

Topic: Covid drug

Free Covid precaution doses for 18-59 age group from July 15 at govt centres

As part of Centre’s Azadi Ka Amrit Mahotsav, this initiative will continue for 75 days.

WHO recommends two new Covid drugs, in discussions to secure ‘equitable access’

Extent to which Baricitinib & Sotrovimab will save lives depends on how available, affordable they will be, says WHO. New guidelines advise against use of Remdesivir, Ivermectin.

WHO approves Glaxo and Eli Lilly drugs to treat Covid amid Omicron surge

Eli Lilly’s rheumatoid arthritis drug and GlaxoSmithKline's monoclonal antibody won the WHO nod.

Antiviral Molnupiravir not in govt Covid protocol, but ‘millions of doses’ distributed in a week

Pharma companies say doctors working in community settings have begun pre-ordering the drug, several manufacturers gearing up to meet demand.

Scientists launch hunt to find naturally Covid-resistant people, 1,000 volunteers to be enrolled

The study looks for people genetically resistant to SARS-CoV-2 virus — if such natural immunity exists. Candidates are one of a couple, where only one partner fell sick, despite close contact.

No benefits of Doxycycline found in UK Covid patients, write Oxford researchers in Lancet study

According to researchers, the drug that has been commonly used to treat Covid respiratory symptoms does not reduce recovery time, hospital admissions, or deaths related to Covid.

Has Covid exposed limitations of ‘secretive’ ICMR? Some experts think so

The ICMR has increasingly drawn criticism from India's doctors and scientists, who have questioned its drug recommendations & lack of transparency on data related to variants.

Pharma firms and diagnostics developers need to unite. They are catalysts for saving lives

Studies of drugs like remdesivir and hydroxychloroquine were underpowered and small, and the results were conflicting and, in many cases, inconclusive.

Molnupiravir helps in faster recovery of mild Covid patients, says Hetero after phase 3 trials

Hyderabad-based pharma company, Hetero, announced promising interim results of phase 3 trials and has approached DCGI for emergency use authorisation for the drug in India.

Why Covid drug Ivermectin remains popular despite warnings & lack of evidence on efficacy

University of Oxford has launched a large study to investigate the use of Ivermectin for Covid-19 treatment, amid guidelines across the world, warning against the use of the drug. 

On Camera

Trump threatened to redraw the map. Greenland deal shows the limits of his disruption

The bargain was never sovereignty in exchange for security. It was extensive American military freedom inside continuing Danish sovereignty.

Tiruppur’s success runs on cheap cotton. India needs to ask who pays for it

Repeated changes in cotton import duty have prioritised textile competitiveness when mills face high input costs. But policy can also put pressure on farmgate prices.

At Tejas trainer handover, Rajnath warns delays can lead to ‘technology obsoletion’

HAL finally closes 2010 Tejas order but work remains on Mk1A and the first delivery is unlikely before IAF chief retires end of October.

Bangladesh isn’t a mirror image of Pakistan. Hyphenating them undermines India’s strategic interests

India is caught in a trap of its own making. While BJP may find it convenient to play on insecurities, it gives Pakistan and Bangladesh leverage.